ergotamine has been researched along with Decerebrate Posturing in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centurión, D; Cobos-Puc, LE; Görnemann, T; Lozano-Cuenca, J; Pertz, HH; Ramírez-Rosas, MB; Sánchez-López, A; Villalón, CM | 1 |
| SMIT, H | 1 |
| Arulmani, U; Centurión, D; Sánchez-Lopez, A; Saxena, PR; Vázquez, E; Villalón, CM | 1 |
| Centurión, D; Gupta, S; MaassenVanDenBrink, A; Mehotra, S; Sánchez-López, A; Villalón, CM | 1 |
| Badia, A; Cuffi, L; Moron, A; Vila, E | 1 |
| Grenié, B; Roquebert, J | 1 |
6 other study(ies) available for ergotamine and Decerebrate Posturing
| Article | Year |
|---|---|
Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Decerebrate State; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Ergotamine; Infusions, Intravenous; Male; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Sympathetic Nervous System; Tachycardia | 2009 |
THE REGULATION OF PEPSIN SECRETION IN THE EDIBLE FROG RANA ESCULENTA (L.).
Topics: Animals; Anura; Autonomic Nervous System; Central Nervous System; Decerebrate State; Ergotamine; Hexamethonium Compounds; Histamine; Pepsin A; Pharmacology; Physiology, Comparative; Rana esculenta; Reflex; Research; Splanchnic Nerves; Sympathectomy; Vagotomy; Vagus Nerve | 1964 |
Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Topics: Animals; Autonomic Fibers, Preganglionic; Blood Pressure; Decerebrate State; Desipramine; Disease Models, Animal; Drug Therapy, Combination; Electric Stimulation; Ergotamine; Infusions, Intravenous; Injections, Intravenous; Male; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sympathetic Nervous System; Tachycardia | 2003 |
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Buspirone; Clozapine; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Ergotamine; Heart Rate; Ketanserin; Lisuride; Male; Metergoline; Methiothepin; Methysergide; Phenylephrine; Piperazines; Pizotyline; Prazosin; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Serotonin Receptor Agonists; Yohimbine | 2006 |
Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat.
Topics: Animals; Blood Pressure; Cardiovascular System; Decerebrate State; Electric Stimulation; Ergotamine; Heart Rate; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Catecholamine; Tyramine | 1988 |
Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Decerebrate State; Dihydroergotamine; Electric Stimulation; Ergotamine; Hemodynamics; Male; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1986 |